Abstract
In patients who have ST-segment elevation myocardial infarction (STEMI), a patent infarct-related artery on the initial angiogram is associated with improved clinical outcomes, including decreased mortality. The present study assessed the influence of administering aspirin, β blockers, statins, and angiotensin-converting enzyme inhibitors before STEMI on infarct-related artery patency. Our data demonstrate that patients who have STEMI and receive these medications on an outpatient basis before the event have a higher likelihood of having a patent infarct-related artery compared with patients who do not receive these medications. Further, our data demonstrate a graded association according to the number of such medications being administered: the likelihood of a patent infarct-related artery increased to >50% as the number of these medications increased.
Original language | English (US) |
---|---|
Pages (from-to) | 7-9 |
Number of pages | 3 |
Journal | American Journal of Cardiology |
Volume | 97 |
Issue number | 1 |
DOIs | |
State | Published - Jan 1 2006 |
Externally published | Yes |
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine